ClavystBio
Type
hub
Founded
2022
Funding Rounds
1
Portfolio companies
1
About ClavystBio
ClavystBio is a life-sciences investment platform focused on accelerating biomedical and medtech technologies from Singapore to global markets. Backed by major institutional capital, the organization invests in, supports and scales R&D-driven companies in therapeutics, digital health and medical technologies, providing capital, industry partnerships and board-level support to portfolio companies.
ClavystBio investments captured (1)
| Company Name | Stage | Total Deal Amount | Date |
|---|---|---|---|
| Series B | $14.5m | May 9, 2024 |